Literature DB >> 22975900

Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve.

Dongqing Wang1, Jian Shi, Shaohua Liang, Shiyong Lu, Xiangjie Qi, Qiang Wang, Guojing Zheng, Sheng Wang, Kemin Zhang, Hongfu Liu.   

Abstract

OBJECTIVE: To assess the predictability of dose-volume histogram (DVH) parameters for radiation pneumonitis (RP) using receiver operating characteristic (ROC) curve.
METHODS: One hundred and thirty-five cases of locally advanced non-small cell lung cancer patients treated with three-dimensional radiotherapy and chemotherapy were analyzed retrospectively. The end point of follow-up was ≥2 grade RP defined according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0. The ROC curve was used to explore the predictive sensitivity (SEN), specificity (SPE), positive predictive value (PPV), and negative predictive value (NPV) for potential DVH parameters associated with RP.
RESULTS: Relative volumes of total lungs receiving ≥5 Gy (V(5)), ≥10 Gy (V(10)), ≥13 Gy (V(13)), ≥20 Gy (V(20)), and mean lung dose (MLD), were all correlated to the development of RP (p < 0.05), among which V 5 and V 20 were the most important factors (p = 0.045 and 0.037; OR = 3.166 and 3.030). However, collinearity was found between V(5) and V(20) (Spearman's rho 0.771, p < 0.01). The area under the ROC curve was 0.643 and 0.648 for using V(5) and V(20) as predictors. If predictive cut-off values were established as follows: V(5) = 0.8 and V(20) = 0.3, the parameters could provide predictive SEN, SPE, PPV and NPV were 0.387 and 0.581, 0.882 and 0.701, 0.444 and 0.321, and 0.855 and 0.873, respectively.
CONCLUSIONS: V(5) and V(20) could act as predictors for RP; however, single DVH metrics did not appear to have high predictive power for RP.

Entities:  

Mesh:

Year:  2012        PMID: 22975900     DOI: 10.1007/s12094-012-0931-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  18 in total

1.  Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.

Authors:  Ellen D Yorke; Andrew Jackson; Kenneth E Rosenzweig; Louise Braban; Steven A Leibel; C Clifton Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-04       Impact factor: 7.038

Review 2.  Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.

Authors:  David A Palma; Suresh Senan; Kayoko Tsujino; Robert B Barriger; Ramesh Rengan; Marta Moreno; Jeffrey D Bradley; Tae Hyun Kim; Sara Ramella; Lawrence B Marks; Luigi De Petris; Larry Stitt; George Rodrigues
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-09       Impact factor: 7.038

3.  An improved model for predicting radiation pneumonitis incorporating clinical and dosimetric variables.

Authors:  Peter Jenkins; Joanne Watts
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-03       Impact factor: 7.038

4.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

Authors:  M V Graham; J A Purdy; B Emami; W Harms; W Bosch; M A Lockett; C A Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

5.  Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury.

Authors:  Pehr A Lind; Lawrence B Marks; Donna Hollis; Ming Fan; Su-Min Zhou; Michael T Munley; Timothy D Shafman; Ronald J Jaszczak; R Edward Coleman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

6.  A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.

Authors:  Line Claude; David Pérol; Chantal Ginestet; Lionel Falchero; Dominique Arpin; Michel Vincent; Isabelle Martel; Stéphane Hominal; Jean-François Cordier; Christian Carrie
Journal:  Radiother Oncol       Date:  2004-05       Impact factor: 6.280

7.  Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.

Authors:  Xianglin Yuan; Zhongxing Liao; Zhensheng Liu; Li-E Wang; Susan L Tucker; Li Mao; Xin Shelley Wang; Mary Martel; Ritsuko Komaki; James D Cox; Luka Milas; Qingyi Wei
Journal:  J Clin Oncol       Date:  2009-04-20       Impact factor: 44.544

8.  Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.

Authors:  Katrien De Jaeger; Yvette Seppenwoolde; Harm H Kampinga; Liesbeth J Boersma; José S A Belderbos; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-04-01       Impact factor: 7.038

9.  Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.

Authors:  Hekun Jin; Susan L Tucker; Hui Helen Liu; Xiong Wei; Sue Sun Yom; Shulian Wang; Ritsuko Komaki; Yuhchyau Chen; Mary K Martel; Radhe Mohan; James D Cox; Zhongxing Liao
Journal:  Radiother Oncol       Date:  2008-10-18       Impact factor: 6.280

10.  Functional dosimetric metrics for predicting radiation-induced lung injury in non-small cell lung cancer patients treated with chemoradiotherapy.

Authors:  Dongqing Wang; Jinbo Sun; Jingyu Zhu; Xiaohong Li; Yanbo Zhen; Songtao Sui
Journal:  Radiat Oncol       Date:  2012-05-17       Impact factor: 3.481

View more
  6 in total

Review 1.  Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Uğur Selek; Yasemin Bölükbaşı; James W Welsh; Erkan Topkan
Journal:  Balkan Med J       Date:  2014-09-13       Impact factor: 2.021

2.  Dosimetric Comparison of Different Planning Techniques in Left-sided Whole-Breast Irradiation: A Planning Study.

Authors:  L Nithya; Vineeta Goel; Deepti Sharma; Karthik Vittal; Nidhi Marjara
Journal:  J Med Phys       Date:  2020-10-13

Review 3.  Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury.

Authors:  Zengfu Zhang; Jialin Zhou; Vivek Verma; Xu Liu; Meng Wu; Jinming Yu; Dawei Chen
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

4.  Association between absolute volumes of lung spared from low-dose irradiation and radiation-induced lung injury after intensity-modulated radiotherapy in lung cancer: a retrospective analysis.

Authors:  Jinmei Chen; Jinsheng Hong; Xi Zou; Wenlong Lv; Feibao Guo; Hualan Hong; Weijian Zhang
Journal:  J Radiat Res       Date:  2015-10-09       Impact factor: 2.724

5.  Clinical Management of Risk of Radiation Pneumonia with Serum Markers During the Radiotherapy for Patients with Thoracic Malignant Tumors.

Authors:  Yuxia Deng; Ting Qiu; Nishant Patel; Shi Zhou; Tao Xue; Haijun Zhang
Journal:  Cancer Manag Res       Date:  2019-12-05       Impact factor: 3.989

6.  Dosimetric comparison of dose accumulation between rigid registration and deformation registration in intensity-modulated radiation therapy for large volume non-small cell lung cancer.

Authors:  Jianxin Ren; Guanzhong Gong; Xinsen Yao; Yong Yin
Journal:  Transl Cancer Res       Date:  2019-12       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.